News AstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridge After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in
Events Partner Content 3rd Lab Asset & Facility Management in Pharma Summit Maximize Your Asset Value & Optimize Your Facility
News Tenax trounced by phase 3 heart failure readout Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
